KANNAPOLIS, N.C., Feb. 28, 2022 – Salubrent announces the addition of Bill Conway to its Management Team as Senior Director of Business Development. Conway brings more than 30 years of experience with a broad range of experience with both large and small organizations in contract manufacturing, pharma, biotech, semi-solid, sterile, and packaging technologies.
“Bill excels at driving sales and optimizing commercial and financial performance,” said Salubrent CEO Terry Novak. “He has a proven track record of strategic growth leadership across multiple businesses, and we’re excited to see how he’ll grow Salubrent’s reach both now and in the future.”
Conway received his chemistry degree from Missouri State University. His corporate areas of expertise include budget and expense control, strategic planning, pipeline management, client building and retention, and contracts and negotiations. Conway has held multiple senior management positions at Catalent’s Specialty Technologies, Nitto Avecia Pharma Services, Boehringer Ingelheim, and DSM pharmaceuticals, to name just a few.
